Correlation Between Thioredoxin-Interacting Protein and Nerve Conduction Velocity in Patients With Type 2 Diabetes Mellitus

Correlation Between Thioredoxin-Interacting Protein and Nerve Conduction Velocity in Patients With Type 2 Diabetes Mellitus

Aims: To investigate the correlation between thioredoxin-interacting protein (TXNIP) and peripheral nerve conduction velocity (NCV) in patients with type 2 diabetes mellitus.Methods: In total, 338 patients with type 2 diabetes mellitus (T2DM) were included in this study. We collected the clinical da...

Full description

Bibliographic Details
Main Authors:	Yuan Gao, Shuchun Chen, Minmin Peng, Zi Wang, Luping Ren, Shumin Mu, Meiling Zheng
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2020-07-01
Series:	Frontiers in Neurology
Subjects:	type 2 diabetes mellitus TXNIP peripheral nerve conduction velocity oxidative stress tumor necrosis factor alpha
Online Access:	https://www.frontiersin.org/article/10.3389/fneur.2020.00733/full

Similar Items

Role of Thioredoxin-Interacting Protein in Diseases and Its Therapeutic Outlook
by: Naila Qayyum, et al.
Published: (2021-03-01)

Thioredoxin-Interacting Protein as a Novel Potential Therapeutic Target in Diabetes Mellitus and Its Underlying Complications
by: Wondafrash DZ, et al.
Published: (2020-01-01)

Thioredoxin-interacting protein in diabetic retinal neurodegeneration: A novel potential therapeutic target for diabetic retinopathy
by: Chengzhi Liu, et al.
Published: (2022-08-01)

Diabetes regulates fructose absorption through thioredoxin-interacting protein
by: James R Dotimas, et al.
Published: (2016-10-01)

Thioredoxin/Txnip: Redoxisome, As a Redox Switch for the Pathogenesis of Diseases
by: Eiji eYoshihara, et al.
Published: (2014-01-01)

Mitochondrial dysfunction mediated by thioredoxin-interacting protein: A crucial determinant in di(2-ethylhexyl) phthalate-induced liver failure
by: Peng Xu, et al.
Published: (2024-03-01)

Immunomodulatory Role of Thioredoxin Interacting Protein in Cancer’s Impediments: Current Understanding and Therapeutic Implications
by: Ramkumar Katturajan, et al.
Published: (2022-11-01)

Thioredoxin interacting protein regulates age-associated neuroinflammation
by: Saifudeen Ismael, et al.
Published: (2021-08-01)

Jinmaitong Ameliorates Diabetic Peripheral Neuropathy Through Suppressing TXNIP/NLRP3 Inflammasome Activation In The Streptozotocin-Induced Diabetic Rat Model
by: Sun Q, et al.
Published: (2019-10-01)

A pan-cancer analysis of thioredoxin-interacting protein as an immunological and prognostic biomarker
by: Xuxue Guo, et al.
Published: (2022-07-01)

Thioredoxin-interacting protein-activated intracellular potassium deprivation mediates the anti-tumour effect of a novel histone acetylation inhibitor HL23, a fangchinoline derivative, in human hepatocellular carcinoma
by: Yuanjun Lu, et al.
Published: (2023-09-01)

Correlation Between Hemoglobin Glycosylation Index and Nerve Conduction Velocity in Patients with Type 2 Diabetes Mellitus
by: Li Z, et al.
Published: (2021-12-01)

PKC Delta Activation Promotes Endoplasmic Reticulum Stress (ERS) and NLR Family Pyrin Domain-Containing 3 (NLRP3) Inflammasome Activation Subsequent to Asynuclein-Induced Microglial Activation: Involvement of Thioredoxin-Interacting Protein (TXNIP)/Thioredoxin (Trx) Redoxisome Pathway
by: Manikandan Samidurai, et al.
Published: (2021-07-01)

Slow flow induces endothelial dysfunction by regulating thioredoxin-interacting protein-mediated oxidative metabolism and vascular inflammation
by: Yongshun Wang, et al.
Published: (2022-11-01)

Transcriptomic Analysis of the Effect of Metformin against Cisplatin-Induced Ototoxicity: A Potential Mechanism of Metformin-Mediated Inhibition of Thioredoxin-Interacting Protein (Txnip) Gene Expression
by: Sehee Lee, et al.
Published: (2022-12-01)

The Emerging Role of Metabolism in Brain-Heart Axis: New Challenge for the Therapy and Prevention of Alzheimer Disease. May Thioredoxin Interacting Protein (TXNIP) Play a Role?
by: Lorena Perrone, et al.
Published: (2021-11-01)

Nerve conduction velocity is independently associated with bone mineral density in type 2 diabetes mellitus
by: Xiao-jing Chen, et al.
Published: (2023-02-01)

A Fluorine-19 Magnetic Resonance Probe, Shiga-Y5, Downregulates Thioredoxin-Interacting Protein Expression in the Brain of a Mouse Model of Alzheimer’s Disease
by: Aslina Pahrudin Arrozi, et al.
Published: (2021-09-01)

Studying the Effect of Adding Alpha Lipoic Acid to Gabapentin to Improve Nerve Conduction Velocity and Glycemic Control of Patients with Diabetic Neuropathy (Sample of Iraqi population)
by: Rusul AbdulKareem Hadi, et al.
Published: (2020-06-01)

Reduced Peripheral Nerve Conduction Velocity is Associated with Alzheimer’s Disease: A Cross-Sectional Study from China
by: Qian X, et al.
Published: (2022-02-01)

TXNIP induces growth arrest and enhances ABT263‐induced apoptosis in mixed‐lineage leukemia‐rearranged acute myeloid leukemia cells
by: Mina Noura, et al.
Published: (2020-08-01)

Endothelial Thioredoxin-Interacting Protein Depletion Reduces Hemorrhagic Transformation in Hyperglycemic Mice after Embolic Stroke and Thrombolytic Therapy
by: Mohd. Salman, et al.
Published: (2021-09-01)

Oral intake of titanium dioxide nanoparticles affect the course and prognosis of ulcerative colitis in mice: involvement of the ROS-TXNIP-NLRP3 inflammasome pathway
by: Shumin Duan, et al.
Published: (2023-06-01)

Thioredoxin-1 distinctly promotes NF-κB target DNA binding and NLRP3 inflammasome activation independently of Txnip
by: Jonathan Muri, et al.
Published: (2020-02-01)

COMPARISON OF NERVE CONDUCTION VELOCITY IN TEENAGERS WITH DIFFERENT IQ
by: S KHOSRAVI
Published: (2002-06-01)

Dorsal cutaneous branch of ulnar nerve: an appraisal on the anatomy, injuries and application of conduction velocity studies in diagnosis
by: GARIBALDI SOLANGE G, et al.
Published: (2000-01-01)

ITCH facilitates proteasomal degradation of TXNIP in hypoxia‐ induced lung cancer cells
by: Qian Sun, et al.
Published: (2022-08-01)

Verapamil Ameliorates Hepatic Metaflammation by Inhibiting Thioredoxin-Interacting Protein/NLRP3 Pathways
by: Feng Zhou, et al.
Published: (2018-10-01)

Inflammation and Aortic Pulse Wave Velocity: A Multicenter Longitudinal Study in Patients With Inflammatory Bowel Disease
by: Luca Zanoli, et al.
Published: (2019-02-01)

Cochlear Marginal Cell Pyroptosis Is Induced by Cisplatin via NLRP3 Inflammasome Activation
by: Wenting Yu, et al.
Published: (2022-04-01)

Effect of backpack load on nerve conduction velocity and risk of peripheral neuropathy in upper extremities of undergraduate medical students carrying backpack
by: Jagdish C Hundekari, et al.
Published: (2022-12-01)

Signaling Pathway of Taurine-Induced Upregulation of TXNIP
by: Hideo Satsu, et al.
Published: (2022-07-01)

TXNIP/TBP-2: A Master Regulator for Glucose Homeostasis
by: Eiji Yoshihara
Published: (2020-08-01)

High TXNIP expression accelerates the migration and invasion of the GDM placenta trophoblast
by: Rina Sa, et al.
Published: (2023-04-01)

Phosphorylation of TXNIP by AKT Mediates Acute Influx of Glucose in Response to Insulin
by: Althea N. Waldhart, et al.
Published: (2017-06-01)

PIAS3 promotes ferroptosis by regulating TXNIP via TGF-β signaling pathway in hepatocellular carcinoma
by: Wenfang Bao, et al.
Published: (2023-10-01)

Velocity of nerve conduction of the tibial and peroneal nerves of Jordan's national badminton team
by: Nedal Banysaeed, et al.
Published: (2024-04-01)

Long-Term IGF1 Stimulation Leads to Cellular Senescence via Functional Interaction with the Thioredoxin-Interacting Protein, TXNIP
by: Karthik Nagaraj, et al.
Published: (2022-10-01)

Motor fiber function in spinal muscular atrophy—analysis of conduction velocity distribution
by: Magdalena Koszewicz, et al.
Published: (2023-12-01)

Evaluating the Proliferation of Human PeripheralBlood Mononuclear Cells Using MTT Assay
by: Nada Molaae, et al.
Published: (2017-03-01)